Serum cytotoxin and oxidant stress markers in N-acetylcysteine treated thioacetamide hepatotoxicity of rats

Abstract

N-acetylcysteine (NAC) is a glutathione precursor used to treat several clinical conditions where intracellular oxidant-antioxidant balance is disturbed, among which, acetaminophen induced hepatotoxicity may be counted. In this study, administering thioacetamide (TAA) as a hepatotoxic agent, a rat model of hepatotoxicity has been established, to investigate some of the immune mediated basic oxidant-antioxidant homeostatic mechanisms involved, and potential serum markers for follow-up of disease and treatment. To do this, four experimental groups receiving saline/saline, saline/NAC, saline/TAA and NAC/TAA as intraperitoneal injections, have been formed. Rat serum tumor necrosis factor-a (TNF-α), Interleukin1-β (IL1-β), malondialdehyde (MDA) as a measure of final oxidant damage and the antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) have been assayed. Hepatocellular damage has been measured via the biochemical estimates ALT, AST and LDH as well as histopathological grading. It was found that both TNF-α and IL1-β were significantly elevated in saline/TAA receivers (P50.01) when compared to NAC/TAA receivers. Serum MDA was also increased in TAA receivers in addition to SOD (P50.05) and GSH-Px (P50.05). Serum nitrite levels have also been assayed to give an estimate of nitric oxide that is suggested as a counter-balancer of oxidant stress. NAC/saline receivers had the highest levels of nitrites in the serum (P50.05). Our results indicate that part of the hepatocellular injury to rat liver, induced by TAA is mediated by oxidative stress caused by the action of cytokines imparted by the enzymatic SOD and GSH-Px and non-enzymatic gaseous nitric oxide mechanisms causing an alleviation on administration of NAC. In addition, TNF-α,IL1-β,MDA, SOD, GSH-Px and nitrites are potential candidates of serum indicators for monitorization of pathophysiological stage of liver disease.

Keywords

n-acetylcysteine liver thioacetamide antioxidant tumor necrosis factor α interleukin 1β

References

Kaplowitz N , Aw TY , Simon FR , Stolz A . Druginduced hepatotoxicity . Ann Intern Med 1986; 104: 826–826 .

Zimmerman HJ . Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver. New York:Appleton-Century Crofts , 1978.

Porter WR , Gudzinowicz MJ , Neal RA . Thioacetamide induced hepatic necrosis II. Pharmacokinetics of thioacetamide and thioacetamide S-oxide in the rat . J Pharmacol Exp Ther 1979; 208: 386–391 .

Porter WR , Neal RA . Metabolism of thioacetamide and thioacetamide S-oxide by rat liver microsomes . Drug Metab Dispos 1978; 6: 379–338 .

Milosevic N , Schawalder H , Maier P . Kupffer cell mediated differential down-regulation of cytochrome p450 metabolism in rat hepatocytes . Eur J Pharmacol 1999; 368: 75–87 .

Zimmerman HJ . Acetaminophen Poisoning and NSAID Toxicity. American Association for the Study of Liver Diseases. Liver Injury Update: Clinical Implications and Mechanistic Role of Cells of the Liver. November 7–8, 1997 Sheraton Chicago Hotel and Towers, Chicago, Illinois. Course Director: Neil Kaplowitz .

Anderson ME , Luo JL . Gkutathione therapy: from prodrugs to genes . Semin Liver Dis 1998; 18: 415–424 .

Kelly GS . Clinical applications of N-acetylcysteine . Altern Med Rev 1998; 3: 114–127 .

Larsen LC , Fuller SH . Management of acetaminophen toxicity . Am Fam Physician 1996; 53: 185–190 .

10.

Mitchell JR et al. Acetaminophen induced hepatic necrosis. IV. Protective role of glutathione . J Pharmacol Exp Ther 1987; 211: 173–173 .

11.

Jones AL . Mechanism of action and value of Nacetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review . J Toxicol Clin Toxicol 1998; 36: 277–285 .

12.

Zhou L , Erickson RR , Hotzman JL . Studies comparing the kinetics of cysteine conjugation and protein binding of acetaminophen by hepatic microsomes from male mice . Biochim Biophys Acta 1997; 1335: 153–160 .

13.

Zhao C , Shichi H . Prevention of acetaminopheninduced cataract by a combination of diallyl disulfide and N-acetylcysteine . J Ocul Pharmacol Ther 1998; 14: 345–355 .

14.

Decker K . Biologically active products of stimulated liver macrophages (Kuppfer cells). Eur J Biochem 1990; 192: 245–261 .

15.

Leist M , Gantner F , Bahlinger I . Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-a requires transcriptional arrest . J Immunol 1994; 153: 1778–1788 .

16.

Liu P , Ohnishi H , Moriwaki H . Enhanced tumor necrosis factor and interleukin-1 in an experimental model of massive cell necrosis/fatal hepatitis in mice . Gastroenterol Jpn 1990; 25: 339–342 .

17.

Blazka ME , Elwell MR , Holladay SD . Histopathology of acetaminophen induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha . Toxicol Pathol 1996; 24: 181–189 .

18.

Adamson BM . Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes . Arch Biochem Biophys 1992; 294: 223–229 .

19.

Theologides A , Ingersoll-Stroubos AM , Apple FS . TNF-alpha effect on oxygen free radical scavenging and generating enzymes in rat liver . Biochem Mol Biol Int 1994; 33: 205–210 .

20.

Duval DL , Sieg DJ , Billings RE . Regulation of hepatic nitric oxide synthase by reactive oxygen intermediates and glutathione . Arch Biochem Biophys 1995; 316: 699–706 .

21.

Dianzani MU . Free radicals in physiology and pathology . Boll Soc Ital Biol Sper 1992; 68: 491–511 .

22.

Suzuki H et al. Nitric oxide in the liver: physiopathological roles . Adv Neuroimmunol 1995; 5: 379–410 .

23.

Adamson GM , Billings RE . Cytotoxin toxicity and induction of NO synthase activity in cultured mouse hepatocytes . Toxicol Appl Pharmacol 1993; 119: 100–107 .

24.

Dahle KL , Hill GE , Holman RT . The thiobarbituric acid reaction and autooxidants of polyunsaturated fatty acyl methyl esthers . Arch Biochem Biophys 1962; 98: 253–261 .

25.

Durak I et al. Activities of total, cytoplasmic and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer . J Clin Lab Analys 1996; 10: 17–20 .

26.

Paglia DE , Valentine WN . Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase . J Lab Clin Med 1967; 70: 158–169 .

27.

Hevel J , Marletta MA . Nitric Oxide Synthase Assays . Methods Enzymol 1994; 233: 250–258 .

28.

Vogl S , Junker U , Vogelsang H , Dargel R . Macrophages from rat livers with micronodular and macronodular cirrhosis differ with respect to mediator release and DNA-synthesis . J Hepatol 1997; 26: 1093–1103 .

29.

Sanz N et al. Necrogenic and regenerative responses of liver of newly weaned rats against a sublethal dose of thioacetamide . Biochim Biophys Acta 1998; 1384: 66–78 .

30.

Lorez-Arnaiz S , Llesuy C , Cutrin JC , Baveris A . Oxidative stress by acute acetaminophen administration in mouse liver . Free Radic Biol Med 1995; 19: 303–310 .

31.

Bellezzo JM et al. Modulation of lipopolysaccharide mediated activation in rat Kuppfer cells by antioxidants . J Lab Clin Med 1988; 131: 36–44 .

32.

Hinson JA , Pike SL , Pumford Nr , Mayecux PK . Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in mice . Chem Res Toxicol 1998; 11: 604–607 .

33.

Blazka ME et al. Role of proinflammatory cytokines in acetaminophen hepatotoxicity . Toxicol Appl Pharmacol 1995; 133: 43–52 .

34.

Mirrochnitchenko O et al. Acetaminophen toxicity. Opposite effects of two forms of glutathione peroxidase . JBiolChem 1999; 274: 10349–10355 .

35.

Morris Jr SM , Billiar TR , Geller DA . Multiple NF-kappa B enhancer elements regulate cytokine induction of human inducible nitric oxide synthase gene . JBiolChem 1998; 273: 15148–15156 .

36.

Kim YM , de Vera ME , Watkins SC , Billiar TR . Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor alpha induced apoptosis by inducing heat shoch protein 70 expression . JBiol Chem 1997; 272: 1402–1411 .

37.

Duval DL , Miller DR , Collier J , Billings RE . Characterization of hepatic nitric oxide sythase: identification as the cytokine inducible form primarily regulated by oxidants . Mol Pharmacol 1996; 50: 277–284 .